A study led by Robert Langer and Li-Huei Tsai of the Picower Institute, presents “miBrains,” a 3D human brain tissue platform designed for disease modeling and drug testing. Described in PNAS, the customizable, scalable models are cultured from donors’ induced pluripotent stem cells, and integrate all major brain cell types.